Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UPRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RNFT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMKLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
OR51A1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HHIP-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCL15-CCL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INPP5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSN-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD209 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORBS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL1A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on